Wall Street Associates’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Wall Street Associates’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.18M	Hold	1,208	–	–	0.78%	42
2016 Q3	$1.61M	Hold	1,208	–	–	0.55%	80
2016 Q2	$1.06M	Hold	1,208	–	–	0.42%	92
2016 Q1	$1.69M	Hold	1,208	–	–	0.7%	53
2015 Q4	$2.23M	Sell	1,208 -42	-3%	-$84K	0.63%	42
2015 Q3	$2.44M	Hold	1,250	–	–	0.47%	72
2015 Q2	$2.83M	Hold	1,250	–	–	0.27%	112
2015 Q1	$3.51M	Buy	+1,250	New	+$3.28M	0.33%	100

Other funds holding TCON

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

CAM

ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return

Wall Street Associates's TCON Position: Q4 2016 in Review

Wall Street Associates held its TRACON Pharmaceuticals, Inc. Common Stock (TCON) position steady in Q4 2016 at 1,208 shares worth $1.18M. The position accounts for 0.78% of the portfolio, ranked #42.

Wall Street Associates first reported a position in TCON in Q1 2015 and has held it in 8 quarters since. The position peaked at $3.51M in Q1 2015. 31 funds tracked by Wall St. Rank hold TCON as of Q4 2016.

Wall Street Associates held 1,208 shares of TRACON Pharmaceuticals, Inc. Common Stock worth $1.18M as of Q4 2016.
Wall Street Associates left its TRACON Pharmaceuticals, Inc. Common Stock share count unchanged in Q4 2016.
TRACON Pharmaceuticals, Inc. Common Stock made up 0.78% of Wall Street Associates's portfolio in Q4 2016, its #42 holding.
Wall Street Associates first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q1 2015 and has held it in 8 quarters since.
Wall Street Associates's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $3.51M in Q1 2015.
31 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q4 2016.

Based on Wall Street Associates's 13F filing for Q4 2016, filed 18 Jan 2017.